GenSight Biologics S.A. Profile Avatar - Palmy Investing

GenSight Biologics S.A.

GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its pr…

Biotechnology
FR, Paris [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

GenSight Biologics S.A. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
0.0 IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
YoY Trends
  • No trends presentable at the moment.

Spending By Type

Awards
Obligations
Contracts IDV Contracts Grants Loans Direct Other

GenSight Biologics S.A. can't present spending by time.

End of SIGHT.PA's Analysis
CIK: - CUSIP: F4374K117 ISIN: FR0013183985 LEI: - UEI: -
Secondary Listings
SIGHT.PA has no secondary listings inside our databases.